Kunkel Lori Anne has filed 22 insider transactions across 3 companies since May 2023.
Most recent transaction: a grant/award of 17126 shares of Enliven Therapeutics, Inc. ($ELVN) on February 12, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 12, 2026 | Enliven Therapeutics, Inc. | $ELVN | Kunkel Lori Anne | Not found | A | Stock Option (right to buy) | 17126 | $0.00 | 17,126.0000 | 62,093,795 | 9999.99% | 0.03% |
| Jan. 2, 2026 | Oric Pharmaceuticals, Inc. | $ORIC | Kunkel Lori Anne | Not found | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 98,953,331 | 9999.99% | 0.04% |
| Dec. 17, 2025 | Enliven Therapeutics, Inc. | $ELVN | Kunkel Lori Anne | Not found | M | Common Stock | 15958 | $1.12 | 61,884.0000 | 62,093,795 | 34.75% | 0.03% |
| Dec. 17, 2025 | Enliven Therapeutics, Inc. | $ELVN | Kunkel Lori Anne | Not found | M | Stock Option (right to buy) | 15958 | $0.00 | 3,741.0000 | 62,093,795 | 81.01% | 0.03% |
| Dec. 8, 2025 | Oric Pharmaceuticals, Inc. | $ORIC | Kunkel Lori Anne | Not found | M | Common Stock | 10000 | $7.90 | 84,200.0000 | 98,953,331 | 13.48% | 0.01% |
| Dec. 8, 2025 | Oric Pharmaceuticals, Inc. | $ORIC | Kunkel Lori Anne | Not found | M | Stock Option (right to buy) | 10000 | $0.00 | 15,600.0000 | 98,953,331 | 39.06% | 0.01% |
| Dec. 4, 2025 | Oric Pharmaceuticals, Inc. | $ORIC | Kunkel Lori Anne | Not found | M | Stock Option (right to buy) | 5534 | $0.00 | 0.0000 | 98,953,331 | 100.00% | 0.01% |
| Dec. 4, 2025 | Oric Pharmaceuticals, Inc. | $ORIC | Kunkel Lori Anne | Not found | M | Common Stock | 5534 | $3.75 | 74,200.0000 | 98,953,331 | 8.06% | 0.01% |
| May 19, 2025 | Nurix Therapeutics, Inc. | $NRIX | Kunkel Lori Anne | Director | A | Director Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 75,886,817 | 9999.99% | 0.03% |
| March 3, 2025 | Oric Pharmaceuticals, Inc. | $ORIC | Kunkel Lori Anne | Not found | M | Stock Option (right to buy) | 27666 | $0.00 | 5,534.0000 | 69,727,940 | 83.33% | 0.04% |
| March 3, 2025 | Oric Pharmaceuticals, Inc. | $ORIC | Kunkel Lori Anne | Not found | M | Common Stock | 20500 | $6.33 | 68,666.0000 | 69,727,940 | 42.56% | 0.03% |
| March 3, 2025 | Oric Pharmaceuticals, Inc. | $ORIC | Kunkel Lori Anne | Not found | M | Common Stock | 27666 | $3.75 | 48,166.0000 | 69,727,940 | 134.96% | 0.04% |
| March 3, 2025 | Oric Pharmaceuticals, Inc. | $ORIC | Kunkel Lori Anne | Not found | M | Stock Option (right to buy) | 20500 | $0.00 | 0.0000 | 69,727,940 | 100.00% | 0.03% |
| Feb. 6, 2025 | Enliven Therapeutics, Inc. | $ELVN | Kunkel Lori Anne | Not found | A | Stock Option (right to buy) | 15368 | $0.00 | 15,368.0000 | 47,072,532 | 9999.99% | 0.03% |
| Jan. 2, 2025 | Oric Pharmaceuticals, Inc. | $ORIC | Kunkel Lori Anne | Not found | A | Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 69,727,940 | 9999.99% | 0.05% |
| July 17, 2024 | Nurix Therapeutics, Inc. | $NRIX | Kunkel Lori Anne | Director | G | Common Stock | 54027 | $0.00 | 0.0000 | 54,337,901 | 100.00% | 0.10% |
| June 12, 2024 | Oric Pharmaceuticals, Inc. | $ORIC | Kunkel Lori Anne | Not found | A | Stock Option (right to buy) | 25600 | $0.00 | 25,600.0000 | 51,450,848 | 9999.99% | 0.05% |
| June 3, 2024 | Oric Pharmaceuticals, Inc. | $ORIC | Kunkel Lori Anne | Not found | M | Stock Option (right to buy) | 20500 | $0.00 | 33,200.0000 | 51,450,848 | 38.18% | 0.04% |
| June 3, 2024 | Oric Pharmaceuticals, Inc. | $ORIC | Kunkel Lori Anne | Not found | M | Common Stock | 20500 | $3.75 | 20,500.0000 | 51,450,848 | 9999.99% | 0.04% |
| May 20, 2024 | Nurix Therapeutics, Inc. | $NRIX | Kunkel Lori Anne | Director | A | Director Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 54,337,901 | 9999.99% | 0.05% |
| April 8, 2024 | Enliven Therapeutics, Inc. | $ELVN | Kunkel Lori Anne | Not found | A | Stock Option (right to buy) | 37882 | $0.00 | 37,882.0000 | 35,546,215 | 9999.99% | 0.11% |
| May 4, 2023 | Nurix Therapeutics, Inc. | $NRIX | Kunkel Lori Anne | Director | A | Director Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 48,607,990 | 9999.99% | 0.05% |